• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(TSX:SVA)

0.1750 -0.0050 (-2.78%)
Streaming Delayed Price Updated: 3:45 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 747,400
Open 0.1800
Bid (Size) 0.1750 (25)
Ask (Size) 0.1800 (695)
Prev. Close 0.1800
Today's Range 0.1700 - 0.1800
52wk Range 0.1500 - 0.4000
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual Report
May 22, 2025
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend
April 30, 2025
From Sinovac Biotech Ltd.
Via Business Wire

Performance

YTD
-23.9%
-23.9%
1 Month
-10.3%
-10.3%
3 Month
-12.5%
-12.5%
6 Month
-20.5%
-20.5%
1 Year
-41.7%
-41.7%

More News

Read More
SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital
April 29, 2025
From Sinovac Biotech Ltd.
Via Business Wire
Sernova Announces Key New Executive Appointments
October 11, 2024
Via TheNewswire.com
Vivo Capital Files Lawsuits to Protect Sinovac Shareholders from the New Board’s Value Destructive Actions
April 23, 2025
From Vivo Capital
Via Business Wire
SINOVAC Announces Decision to Declare Cash Dividend
April 01, 2025
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Announces New Board Member and Chairman of the Audit Committee
March 28, 2025
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
February 28, 2025
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Issues Statement Regarding Privy Council Judgment
January 16, 2025
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
December 16, 2024
From Sinovac Biotech Ltd.
Via Business Wire
Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa
October 03, 2024
Via NewMediaWire
SINOVAC Reports Unaudited First Half of 2024 Financial Results
August 16, 2024
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
April 29, 2024
From Sinovac Biotech Ltd.
Via Business Wire
Sernova Provides Positive Clinical and Platform Portfolio Update
April 02, 2024
Via TheNewswire.com
Sinovac Amends Shareholder Rights Plan
February 21, 2024
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
January 18, 2024
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
September 11, 2023
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
September 05, 2023
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
August 29, 2023
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Announces Change of Legal Representative of Sinovac Beijing
August 28, 2023
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited First Half of 2023 Financial Results
August 15, 2023
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
May 10, 2023
From Sinovac Biotech Ltd.
Via Business Wire
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
May 01, 2023
From Sinovac Biotech Ltd.
Via Business Wire
Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference
February 22, 2023
Via Investor Brand Network
Sinovac Amends Shareholder Rights Plan
February 22, 2023
From Sinovac Biotech Ltd.
Via Business Wire

Frequently Asked Questions

Is SVA publicly traded?
Yes, SVA is publicly traded.
What exchange does SVA trade on?
SVA trades on the Toronto Stock Exchange
What is the ticker symbol for SVA?
The ticker symbol for SVA is SVA on the Toronto Stock Exchange
What is the current price of SVA?
The current price of SVA is 0.1750
When was SVA last traded?
The last trade of SVA was at 05/30/25 03:45 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap